Dynamic Technology Lab Private LTD Innoviva, Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$11.39 - $13.72 $116,371 - $140,177	10,217 New	10,217 $130,000
Q3 2022 Nov 14, 2022	BUY	$11.61 - $15.22 $449,678 - $589,501	38,732 New	38,732 $450,000
Q1 2022 May 16, 2022	SELL	$15.39 - $20.25 $435,967 - $573,642	-28,328 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$15.91 - $18.72 $450,698 - $530,300	28,328 New	28,328 $489,000
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $147,291 - $206,036	-14,328 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $143,996 - $208,472	14,328 New	14,328 $151,000
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $132,087 - $150,740	-10,083 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$13.69 - $20.06 $138,036 - $202,264	10,083 New	10,083 $141,000

232

79.1M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.28B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.